We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZS:NASDAQZscaler, Inc. Analysis

Data as of 2026-06-17 - not real-time

$124.38

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Zscaler (ZS) is trading well below its 20‑day and 50‑day moving averages, with the price near the identified support level and a neutral trend despite a bearish MACD and an RSI hovering around the mid‑40s, indicating limited short‑term momentum. Volatility is extremely high at over 130% for the past 30 days, and volume has been tapering, which adds to the near‑term uncertainty. Fundamentally, the company delivered 25% year‑over‑year revenue growth and maintains a strong gross margin above 75%, but operating and profit margins remain negative, and cash flow is still the primary source of earnings. The balance sheet shows ample cash exceeding $3 billion against debt of roughly $1.9 billion, yielding a high debt‑to‑equity ratio, while the DCF model values the stock near $260, implying more than 50% upside from the current price. Recent material events include a 30% price plunge after the Q3 results, removal from the Nasdaq‑100 index, senior sales departures, and multiple investigations, all of which have pressured the share price but also created a potential entry point. Looking ahead, the rollout of AI‑focused Zero Trust products and a forward PE of 27—well below the industry average of 37—support a longer‑term bullish case, especially as analysts collectively rate the stock as a “Buy.”

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Significant price discount to DCF fair value
  • Strong cash position offsetting debt concerns
  • Recent share‑price weakness creating upside potential

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained 25% revenue growth and expanding AI/Zero‑Trust product suite
  • Forward earnings estimate turning positive with margin improvement expectations
  • Analyst consensus of buy and target prices near $190

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Secular demand for cloud‑native security and Zero Trust architecture
  • Undervaluation relative to intrinsic fair value and industry multiples
  • Robust balance sheet enabling continued investment in innovation

Key Metrics & Analysis

Financial Health

Revenue Growth25.40%
Profit Margin-2.44%
P/E Ratio27.1
ROE-3.71%
ROA-1.36%
Debt/Equity78.94
P/B Ratio8.5
Op. Cash Flow$1.1B
Free Cash Flow$1.1B
Industry P/E37.0

Technical Analysis

TrendNeutral
RSI40.1
Support$119.50
Resistance$191.25
MA 20$141.32
MA 50$141.00
MA 200$212.33
MACDBearish
VolumeDecreasing
Fear & Greed Index88.5

Valuation

Fair Value$259.58
Target Price$193.05
Upside/Downside55.21%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.00
Volatility132.22%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.